175 related articles for article (PubMed ID: 27388712)
1. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Is there a Spin?
Naudet F
Pharmacopsychiatry; 2016 Nov; 49(6):260-261. PubMed ID: 27388712
[No Abstract] [Full Text] [Related]
2. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-analysis - Comment to Naudet.
Soyka M; Friede M; Schnitker J
Pharmacopsychiatry; 2016 Nov; 49(6):261-262. PubMed ID: 27388713
[No Abstract] [Full Text] [Related]
3. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
Soyka M; Friede M; Schnitker J
Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
[TBL] [Abstract][Full Text] [Related]
4. Opioid Receptor Antagonists in the Treatment of Alcoholism.
Serecigni JG
Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of nalmefene versus placebo in alcohol treatment: reduction in mortality risk.
Roerecke M; Sørensen P; Laramée P; Rahhali N; Rehm J
J Psychopharmacol; 2015 Nov; 29(11):1152-8. PubMed ID: 26349557
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
[TBL] [Abstract][Full Text] [Related]
7. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
[TBL] [Abstract][Full Text] [Related]
8. Nalmefene for alcohol dependence.
Harv Ment Health Lett; 2000 Mar; 16(9):7. PubMed ID: 10677202
[No Abstract] [Full Text] [Related]
9. Opioid antagonists for alcohol dependence.
Rösner S; Hackl-Herrwerth A; Leucht S; Vecchi S; Srisurapanont M; Soyka M
Cochrane Database Syst Rev; 2010 Dec; (12):CD001867. PubMed ID: 21154349
[TBL] [Abstract][Full Text] [Related]
10. Nalmefene. Alcohol dependence: no advance.
Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
[TBL] [Abstract][Full Text] [Related]
11. Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Stevenson M; Pandor A; Stevens JW; Rawdin A; Rice P; Thompson J; Morgan MY
Pharmacoeconomics; 2015 Aug; 33(8):833-47. PubMed ID: 25851485
[TBL] [Abstract][Full Text] [Related]
12. Opioid antagonists in the treatment of alcohol dependence.
O'Leary G; Borrow J; Weiss RD
Curr Psychiatry Rep; 2001 Dec; 3(6):484-8. PubMed ID: 11707162
[TBL] [Abstract][Full Text] [Related]
13. Nalmefene for alcohol dependence: a NICE decision?
Naudet F; Fitzgerald N; Braillon A
Lancet Psychiatry; 2016 Dec; 3(12):1104-1105. PubMed ID: 27889007
[No Abstract] [Full Text] [Related]
14. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
Mason BJ; Salvato FR; Williams LD; Ritvo EC; Cutler RB
Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606
[TBL] [Abstract][Full Text] [Related]
15. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
Mann K; Bladström A; Torup L; Gual A; van den Brink W
Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314
[TBL] [Abstract][Full Text] [Related]
16. Opioid antagonists for the treatment of alcohol dependence.
Yancey JR; Lumbad J
Am Fam Physician; 2011 Nov; 84(9):990-2. PubMed ID: 22046937
[No Abstract] [Full Text] [Related]
17. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
Gual A; He Y; Torup L; van den Brink W; Mann K;
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264
[TBL] [Abstract][Full Text] [Related]
18. Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.
Soyka M
Expert Opin Pharmacother; 2016; 17(4):619-26. PubMed ID: 26810044
[TBL] [Abstract][Full Text] [Related]
19. Trial watch: Nalmefene reduces alcohol use in phase III trial.
Nat Rev Drug Discov; 2011 Aug; 10(8):566. PubMed ID: 21804585
[No Abstract] [Full Text] [Related]
20. Naltrexone for drinking problems: useful further evidence on efficacy.
Chick J
Addiction; 2001 Dec; 96(12):1856. PubMed ID: 11791531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
